Lone Pine Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-587,696
Closed -$324M 32
2022
Q4
$324M Sell
587,696
-297,630
-34% -$158M 3.09% 14
2022
Q3
$449M Sell
885,326
-46,966
-5% -$26.3M 4.23% 10
2022
Q2
$506M Buy
932,292
+411,583
+79% +$227M 4.77% 8
2022
Q1
$308M Buy
+520,709
New +$299M 1.83% 22
2013
Q3
Sell
-2,766,476
Closed -$234M 64
2013
Q2
$234M Buy
+2,766,476
New +$230M 1.14% 38

Other funds holding TMO

Lone Pine Capital's TMO Position: Q1 2023 in Review

Lone Pine Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 587,696 shares — an estimated $324M sold.

Lone Pine Capital first reported a position in TMO in Q2 2013 and held it in 5 quarters. The position peaked at $506M in Q2 2022. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Lone Pine Capital reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Lone Pine Capital sold 587,696 Thermo Fisher Scientific shares in Q1 2023, an estimated $324M.
  • Lone Pine Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 5 quarters.
  • Lone Pine Capital's Thermo Fisher Scientific position peaked at $506M in Q2 2022.
  • 2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Lone Pine Capital's 13F filing for Q1 2023, filed 15 May 2023.